SCHEMBL30738835

SCHEMBL30738835

COc1cc(N2CCC3(CC2)OCCO3)c(F)cc1N1CCC(=O)NC1=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 1/20 0.37
DDB1 Q16531 2/20 0.36
CRBN Q96SW2 2/20 0.36
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 4/20 0.34
POLB P06746 3/20 0.34
NPC1 O15118 2/20 0.34
RAB9A P51151 2/20 0.34
LGMN Q99538 1/20 0.34
MAPT P10636 2/20 0.33
HTT P42858 1/20 0.33
KDM1A O60341 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
MEN1 O00255 1/20 0.33
TNNI3 P19429 1/20 0.33
TNNT2 P45379 1/20 0.33
TNNC1 P63316 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27178764 1.00 FFAR4 (0.37) FFAR4DDB1CRBNKMT2AKDM4E
SCHEMBL30738817 0.84 CRBN (0.40) FFAR4DDB1CRBNKMT2AALDH1A1
SCHEMBL27179079 0.84 CRBN (0.40) FFAR4DDB1CRBNKMT2AALDH1A1
SCHEMBL2766538 0.79 FFAR4 (0.51) FFAR4KMT2AKDM4EALDH1A1POLB
SCHEMBL30738836 0.78 DDB1 (0.44) DDB1CRBNALDH1A1NPC1RAB9A
SCHEMBL27091631 0.78 DDB1 (0.44) DDB1CRBNALDH1A1NPC1RAB9A
SCHEMBL17893742 0.78 FFAR4 (0.41) FFAR4KMT2AKDM4EALDH1A1POLB
SCHEMBL27178766 0.77 FFAR4 (0.38) FFAR4KMT2AKDM4EALDH1A1POLB
SCHEMBL27178719 0.76 CRBN (0.43) DDB1CRBN
SCHEMBL23538506 0.75 CRBN (0.52) DDB1CRBNKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4561999-A1 TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY Abbvie Operations Singapore Pte. Ltd. (SG) 2025-06-04 EP disclosed
CN-119923391-A Targeted protein degradation of PARP14 for use in therapy 艾伯维新加坡运营私人有限公司 2025-05-02 CN disclosed
WO-2024026081-A1 TARGETED PROTEIN DEGRADATION OF PARP14 FOR USE IN THERAPY RIBON THERAPEUTICS, INC. (US) 2024-02-01 WO disclosed